Quidel Corporation (Nasdaq: QDEL) is a California-based leading diagnostic healthcare manufacturer serving to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system. 

Quidel Triage® MeterPro

Quidel Triage® MeterPro is designed to provide diagnostic results quickly and easily. With a variety of immunoassays and the ability to use whole blood, plasma, or urine, the Quidel Triage® MeterPro gives you a

flexible solution at the point-of-care. The platform is as easy as 1, 2, 3:

  1. Add sample to the device using the transfer pipette included in each kit.
  2. Insert the device into the meter.
  3. Read results on display panel or print directly from meter

Quidel Triage® MeterPro Assays

Quidel’s Triage® system of tests comprises a comprehensive test menu that provides the diagnostic answers you need to make rapid, cost-effective treatment decisions in the lab or at the point-of-care (POC). Quidel provides
a diverse immunoassay menu in a variety of tests to provide you with diagnostic answers for quantitative BNP, CK-MB, d-dimer, troponin I and qualitative TOX Drug Screen.

Covid-19 Product Solutions

Quidel is committed to assisting in the global fight against COVID-19 by offering one of the most comprehensive portfolios with technologies ranging from next-generation home and POC rapid antigen tests to high throughput molecular diagnostics.


Sofia, the next generation in diagnostic testing, takes rapid testing to a whole new level. Proven lateral-flow
technology and proprietary advanced fluorescence chemistry and assay development techniques are
all integrated into two small bench top analyzers that can be used near patient and in laboratory settings.